G6PD and COVID-19: Because G6PD enzyme deficiency causes a redox imbalance in red blood cells, leading to hemolysis and tissue damage due to insufficient oxygen transport, COVID-19 may increase the risk of mortality in patients with G6PD enzyme deficiency [20,21,22].